Skip to main content
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FYDRANE 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL Injectable Solution

Contents of the leaflet

  1. Introduction
  2. What is FYDRANE and what is it used for
  3. What you need to know before starting to use FYDRANE
  4. How to use FYDRANE
  5. Possible Side Effects
  6. Storage of FYDRANE
  7. Package Contents and Additional Information

Introduction

Package Leaflet: Information for the User

FYDRANE0.2 mg/ml + 3.1 mg/ml + 10 mg/ml, injectable solution

tropicamide / phenylephrine hydrochloride / lidocaine hydrochloride monohydrate

Read the entire package leaflet carefully before starting to use the medicine, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor, pharmacist, or nurse.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is FYDRANE and what is it used for
  2. What you need to know before starting to use FYDRANE
  3. How to use FYDRANE
  4. Possible side effects
  5. Storage of FYDRANE
  6. Package Contents and Additional Information

1. What is FYDRANE and what is it used for

What is FYDRANE

This medicine is a solution for injection into the eye.

It contains three active substances:

  • Tropicamide, which belongs to a group of medicines that block the passage of impulses through nerves (known as anticholinergics),
  • Phenylephrine (as phenylephrine hydrochloride) which belongs to a group of medicines that mimic the effects of impulses transmitted through certain nerves (which belong to alpha-sympathomimetics),
  • Lidocaine (as lidocaine hydrochloride monohydrate) which belongs to a group of medicines called local anesthetics of the amide type.

What it is used for

This medicine is used only in adults.

It will be administered by your ophthalmic surgeon through an injection into the eye at the start of cataract surgery (opacity of the lens) to dilate the pupil of your eye (mydriasis) and obtain anesthesia in your eye during the surgical procedure.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use FYDRANE

FYDRANE should not be administered to you:

  • if you are allergic to tropicamide, phenylephrine hydrochloride, and/or lidocaine hydrochloride monohydrate or to any of the other components of this medicine (listed in section 6),
  • if you are allergic to amide-type anesthetics (such as articaine, bupivacaine, mepivacaine, prilocaine, ropivacaine),
  • if you are allergic to atropine derivatives.

Warnings and Precautions

FYDRANE is not recommended:

  • in cataract surgery combined with a certain type of eye surgery (vitrectomy),
  • if the anterior part (anterior chamber) of your eye is shallow,
  • if you have ever suffered from an acute increase in eye pressure (acute angle-closure glaucoma).

Consult your doctor if you have:

  • high blood pressure (hypertension)
  • thickening of the arterial walls (arteriosclerosis)
  • any heart disease, and particularly if it affects heart rate,
  • a contraindication to medications that increase blood pressure (vasopressor amines: epinephrine, norepinephrine, dopamine, dobutamine) by systemic route,
  • overactive thyroid gland (hyperthyroidism),
  • prostate gland disorders,
  • seizures (epilepsy),
  • any liver or kidney disease,
  • any respiratory problems,
  • muscle weakness and loss of muscle function (myasthenia gravis).

Using FYDRANE with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.

Pregnancy, Breastfeeding, and Fertility

This medicine should not be used:

  • during pregnancy
  • during breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and Using Machines

FYDRANE has a moderate influence on the ability to drive and use machines. Therefore, you should not drive and/or use machines until your vision is normal.

FYDRANE contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per dose; this is, essentially "sodium-free".

3. How to use FYDRANE

This medicine should only be administered if you have already demonstrated, in a preoperative evaluation, satisfactory pupil dilation with a topical mydriatic.

Dose and Method of Administration

  • FYDRANE injectable solution should be administered by an ophthalmic surgeon, with local anesthesia, at the start of cataract surgery.
  • The recommended dose is 0.2 ml of solution in a single injection. No additional doses should be injected since no cumulative effects have been demonstrated and because an increase in endothelial cell loss has been observed.
  • The same dose is used in adults and in elderly patients.

If you are given too much or too little FYDRANE:

Your medication will be administered by an ophthalmic surgeon. It is unlikely that you will be given an overdose. An overdose may cause loss of corneal endothelial cells (cells of a layer that covers the posterior surface of the cornea).

If you have any further questions about the use of this product, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medicines, this medicine can have side effects, although not everyone gets them.

The most serious known complications occur during or after cataract surgery:

Uncommon: may affect up to 1 in 100 people

  • Damage to the lens (posterior capsule rupture),
  • Inflammation of the retina (cystoid macular edema).

Please seek urgent medical attention in these cases.

Other side effects:

Uncommon: may affect up to 1 in 100 people

  • Headache,
  • Inflammation of the cornea (keratitis), increased pressure in the eye, redness of the eye (ocular hyperemia),
  • High blood pressure (hypertension).

Reporting Side Effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of FYDRANE

Keep out of sight and reach of children.

Do not use this medicine after the expiration date stated on the carton, blister, and ampoule after "EXP.". The expiration date is the last day of the month indicated.

This medicine does not require special storage conditions.

For use in a single eye. This medicine should be used immediately after opening the ampoule.

Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Package Contents and Additional Information

Composition of FYDRANE

  • The active substances are tropicamide 0.04 mg, phenylephrine hydrochloride 0.62 mg, and lidocaine hydrochloride monohydrate 2 mg per 0.2 ml dose, equivalent to 0.2 mg of tropicamide, 3.1 mg of phenylephrine hydrochloride, and 10 mg of lidocaine hydrochloride monohydrate per 1 ml.
  • The other components are: sodium chloride, disodium phosphate dodecahydrate, disodium phosphate dihydrate, disodium edetate, and water for injectable preparations.

Appearance and Packaging of the Product

FYDRANE is a clear, yellow to slightly brownish injectable solution, practically free of visible particles, packaged in a 1 ml topaz glass ampoule. Each sterile ampoule contains 0.6 ml of the injectable solution and is presented alone or with a sterile 5-micron filter needle in a sealed paper/PVC blister.

Each package contains 1, 20, or 100 sterile ampoules (with a sterile 5-micron filter needle). The 5-micron filter needle should only be used to extract the contents of the vial.

All components are for single use only.

Not all package sizes may be marketed.

Marketing Authorization Holder

LABORATOIRES THEA

RUE LOUIS BLÉRIOT, 12

F-63017 CLERMONT-FERRAND CEDEX 2

FRANCE

Manufacturer

DELPHARM TOURS

RUE PAUL LANGEVIN

37170 CHAMBRAY LES TOURS

FRANCE

OR

LABORATOIRES THEA

RUE LOUIS BLÉRIOT, 12

F-63017 CLERMONT-FERRAND CEDEX 2

FRANCE

Local Representative:

LABORATORIOS THEA, S.A.

C/ Enric Granados, nº 86-88, 2ª planta

08008 Barcelona

This medicine is authorized in the Member States of the European Economic Area under the following names:

Austria, Belgium, Bulgaria, Cyprus, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Luxembourg, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, United Kingdom ………………………………. Mydrane

Ireland, Spain …………………………………………. Fydrane

Norway ………………………………………… Mydane

Date of the last revision of this package leaflet: September 2023

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS): http://www.aemps.es/

This information is intended only for healthcare professionals:

Incompatibilities

No incompatibilities of the active substances with most products used in cataract surgery have been reported in the literature, and none were found during clinical trials. For usual viscoelastics, this has also been confirmed by pharmacological interaction tests.

Warnings

Do not use if the blister is damaged or broken. Open only under aseptic conditions to ensure the sterility of the contents.

How to Prepare and Administer FYDRANE

Single use of the solution for one eye by intracameral route only.

FYDRANE should be administered by intracameral injection into the anterior chamber of the eye, by an ophthalmic surgeon, under aseptic conditions recommended for cataract surgery.

Before intracameral injection, the solution should be visually inspected and only used if it is a clear solution with a slight yellow to slightly brownish color and practically free of visible particles.

The recommended dose is 0.2 ml of FYDRANE; no additional dose should be injected since no significant cumulative effects have been demonstrated and because an increase in endothelial cell loss has been observed.

The product should be used immediately after opening the ampoule and should not be reused for the other eye or for any other patient.

Only for the kit presentation (i.e., blister containing an ampoule and a needle): attach the detachable label from the blister to the patient's medical history.

To prepare FYDRANE for intracameral administration, follow these instructions:

Transparent glass ampoule with liquid inside and protective seal on top

Y-shaped connector with three connected tubes and central flow control valve

5-micron filter needle with detailed plunger and sharp tip with explanatory text

Dental paste applicator with interchangeable tip showing disassembly and different white and black tips

Pre-filled syringe with medication showing 0.2 ml graduation and visible needle bevel

  1. Inspect the unopened blister to ensure it is intact. Open the blister by peeling off the laminate under aseptic conditions to ensure the sterility of the contents.
  1. Open the sterile ampoule containing the medicine. To open the OPC (One Point Cut) ampoule, proceed as follows: hold the lower part of the ampoule with your thumb pointing to the colored mark. Hold the upper part of the ampoule with your other hand and, placing your thumb on the colored mark, apply pressure backwards to break the glass at the existing cut under the mark.
  1. Place the sterile 5-micron filter needle (supplied) on a sterile syringe. Remove the protective cap from the sterile 5-micron filter needle and withdraw at least 0.2 ml of injectable solution from the ampoule into the syringe.
  1. Disconnect the needle from the syringe and attach the syringe to a suitable cannula for the anterior chamber.
  1. Carefully expel the air from the syringe. Adjust to 0.2 ml. The syringe is ready for injection.
  1. Slowly inject the 0.2 ml volume from the syringe into the anterior chamber of the eye, through a single injection, via the lateral or main port.

After use, properly dispose of the remaining solution. It should not be kept for future use.

The disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations. Dispose of used needles in a puncture-proof container.

Online doctors for FYDRANE 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL Injectable Solution

Discuss questions about FYDRANE 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL Injectable Solution, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

FYDRANE 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL Injectable Solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in FYDRANE 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL Injectable Solution is tropicamide, combinations. This information helps identify medicines with the same composition but different brand names.

FYDRANE 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL Injectable Solution is manufactured by Laboratoires Thea. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Ophthalmologists, ENT doctors, General medicine doctors may assess whether FYDRANE 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL Injectable Solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, FYDRANE 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL Injectable Solution is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (tropicamide, combinations) include MYDRIASERT 0.28 mg/5.4 mg OPHTHALMIC INSERT, COLIROFTA ATROPINE 10 mg/ml EYE DROPS SOLUTION, COLIROFTA ATROPINE 5 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media